Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank
Hu Y, Li X, Wang X, et al.
Diabetes Obes Metab. Pub. Online 15 Apr 2024.
Leggi
Early-onset type 2 diabetes and tirzepatide treatment: A post hoc analysis from the surpass clinical trial program
Zeitler P, Galindo RJ, Davies MJ, et al.
Diabetes Care. Pub. Online 19 Apr 2024.
Leggi
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan RA, Battelino T, Cos X, et al.
Nat Rev Endocrinol. Pub. Online 8 Apr 2024.
Leggi
Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes
Deng S, Hu X, Zhang X
Diabetes Obes Metab. Pub. Online 15 Apr 2024.
Leggi
Incretin-based investigational therapies for the treatment of MASLD/MASH
Brouwers B, Rao G, Tang Y, et al.
Diabetes Res Clin Pract. Pub. Online 16 Apr 2024.
Leggi
Early metabolic endpoints identify persistent treatment efficacy in recent-onset type 1 diabetes immunotherapy trials
Jacobsen LM, Cuthbertson D, Bundy BN, et al.
Diabetes Care. Pub. Online 15 Apr 2024.
Leggi
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes
Irlik K, Aldosari H, Hendel M, et al.
Diabetes Obes Metab. Pub. Online 11 Apr 2024.
Leggi
Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta-analysis of randomized controlled trials
Grando Alves G, Cunha L, Henkes Machado R, et al.
Diabetes Obes Metab. Pub. Online 11 Apr 2024.
Leggi
Neonatal outcomes according to different glucose threshold values in gestational diabetes: a register-based study
Kariniemi K, Vääräsmäki M, Männistö T, et al.
BMC Pregnancy Childbirth. Pub. Online 12 Apr 2024.
Leggi